BLSA's logo.
Ticker Symbol: BLSA

BCLS Acquisition Corp - Class A

$9.91 - 04-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001823200

Company Profile

BCLS Acquisition Corp. is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies. The Company is sponsored by an affiliate of Bain Capital Life Sciences, a leading life sciences investment manager.

Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: N/A
CEO: N/A
Tags:
  • Finance
  • Financial Conglomerates

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: $10.02 - $10.03
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 14862500

Valuation

Market Cap: 14.9B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A